Development of non-invasive genosensor to diagnose pancreatic cancer using miRNA-196a

Original scientific paper

Authors

  • Namita Sharma Department of Biotechnology, Jaypee Institute of Information Technology, A-10, Sector-62, Noida, Uttar Pradesh, India https://orcid.org/0009-0009-4026-9593
  • Sudha Srivastava Department of Biotechnology, Jaypee Institute of Information Technology, A-10, Sector-62, Noida, Uttar Pradesh, India https://orcid.org/0000-0001-8125-2768

DOI:

https://doi.org/10.5599/jese.2807

Keywords:

DNA biosensor, gold nanoparticles, hybridization, cyclic voltammetry, chronocoulometry, limit of detection

Abstract

This work presents the development of a diagnostic device for pancreatic cancer, one of the deadliest malignancies worldwide. The circulating pancreatic cancer biomarker miRNA-196a was utilized for the development of an electrochemical genosensor due to its stability in biological fluids. Immobilized single-stranded DNA conjugated with gold nanoparticles establishes a sensitive platform for the electrochemical detection of miRNA-196a. The sensor performance was evaluated for probe DNA-miRNA hybridization at optimum temperature (55 °C) using cyclic voltammetry and chronocoulometric techniques, achieving sensitivities of 51.10 µA pg-1 mL cm-2 and 18.28 µC pg-1 mL cm-2, respectively. The device exhibited a wide linear detection range of miRNA-196a from 14.9 aM to 14.9 nM. To the best of our knowledge, for already developed PDAC biosensors using a single biomarker or a panel of biomarkers, the widest detection range for miRNA-196a was reported as 0.05 fM to 50 pM by Guo et al. in 2018. Hence, the developed genosensor, having a detection limit of 14.9 aM and a wide detection range, may prove to be a promising tool in detecting pancreatic cancer at an early stage, and hence improve patient outcomes.

Downloads

Download data is not yet available.

References

[1] G. A. Calin, C. D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, L. Rassenti, T. Kipps, M. Negrini, F. Bullrich, C.M. Croce, Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia, Proceedings of the National Academy of Sciences (PNAS) 99 (2002) 15524-15529. https://doi.org/10.1073/pnas.242606799 DOI: https://doi.org/10.1073/pnas.242606799

[2] R. A. Subramani, L. Gangwani, S. B. Nandy, A. Arumugam, M. Chattopadhyay, R. Lakshmanaswamy, Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis, International Journal of Oncology 47 (2015) 1203-1210. https://doi.org/10.3892/ijo.2015.3129 DOI: https://doi.org/10.3892/ijo.2015.3129

[3] B. Smolarz, A. Durczyński, H. Romanowicz, K. Szyłło, P. Hogendorf, miRNAs in Cancer (Review of Literature), International Journal of Molecular Science 23 (2022) 2805. https://doi.org/10.3390/ijms23052805 DOI: https://doi.org/10.3390/ijms23052805

[4] Y. Peng, C. M. Croce, The role of MicroRNAs in human cancer, Signal Transduction and Targeted Therapy 1 (2016) 15004. https://doi.org/10.1038/sigtrans.2015.4 DOI: https://doi.org/10.1038/sigtrans.2015.4

[5] M. Liu, Y. Du, J. Gao, J. Liu, X. Kong, Y. Gong, Z. Li, H. Wu, H. Chen, Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells, Pancreas 42 (2013) 1169-1181. https://doi.org/10.1097/MPA.0b013e3182962acb DOI: https://doi.org/10.1097/MPA.0b013e3182962acb

[6] M. Bloomston, W. L. Frankel, F. Petrocca, S. Volinia, H. Alder, J. P. Hagan, C. G. Liu, D. Bhatt, C. Taccioli, C. M. Croce, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis, Jama 297 (2007) 1901-1918. https://doi.org/10.1001/jama.297.17.1901 DOI: https://doi.org/10.1001/jama.297.17.1901

[7] F. Huang, J. Tang, X. Zhuang, Y. Zhuang, W. Cheng, W. Chen, H. Yao, S. Zhang, MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha, PloS One 9 (2014) e87897. https://doi.org/10.1371/journal.pone.0087897 DOI: https://doi.org/10.1371/journal.pone.0087897

[8] A. A Tesfaye, A. S Azmi, P. A. Philip, miRNA and gene expression in pancreatic ductal adenocarcinoma, The American Journal of Pathology 189 (2019) 58-70. https://doi.org/10.1016/j.ajpath.2018.10.005 DOI: https://doi.org/10.1016/j.ajpath.2018.10.005

[9] M. Sun, X.-H. Liu, J.-H. Li, J.-S. Yang, E.-B. Zhang, D.-D. Yin, Z.-L. Liu, J. Zhou, Y. Ding, S.-Q. Li, Z.-X. Wang, X.-F. Cao, W. De, MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27kip1, Molecular Cancer Therapeutics 11 (2012) 842-852. https://doi.org/10.1158/1535-7163.MCT-11-1015 DOI: https://doi.org/10.1158/1535-7163.MCT-11-1015

[10] Q. Li, Z. Yang, M. Chen, Y. Liu, Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment, International Journal of Molecular Medicine 37 (2016) 1067-1074. https://doi.org/10.3892/ijmm.2016.2513 DOI: https://doi.org/10.3892/ijmm.2016.2513

[11] J. Li, Q. Liu, L. H. Clark, H. Qiu, V. L. Bae-Jump, C. Zhou, Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use, Future Oncology 13 (2016) 743-753. https://doi.org/10.2217/fon-2016-0328 DOI: https://doi.org/10.2217/fon-2016-0328

[12] Q. Han, C. Zhou, F. Liu, G. Xu, R. Zheng, X. Zhang, MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer, Oncology Reports 34 (2015) 877-883. https://doi.org/10.3892/or.2015.4049 DOI: https://doi.org/10.3892/or.2015.4049

[13] L. Yang, F. Peng, J. Qin, H. Zhou, B. Wang, Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1, Oncology Reports 38 (2017) 2148-2154. https://doi.org/10.3892/or.2017.5873. DOI: https://doi.org/10.3892/or.2017.5873

[14] C. Hu, J. Peng, L. Lv, X. Wang, Y. Zhou, J. Huo, D. Liu, miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1, Oncology Letters 17 (2019) 5201-5209. https://doi.org/10.3892/ol.2019.10186 DOI: https://doi.org/10.3892/ol.2019.10186

[15] J. Ge, Z. Chen, R. Li, T. Lu, G. Xiao, Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer, Cancer Cell International 14 (2014) 128. https://doi.org/10.1186/s12935-014-0128-2 DOI: https://doi.org/10.1186/s12935-014-0128-2

[16] Y. E. Suh, N. Raulf, J. Gäken, K. Lawler, T. G. Urbano, J. Bullenkamp, S. Gobeil, J. Huot, E. Odell, M. Tavassoli, MicroRNA‐196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance, International Journal of Cancer 137 (2015) 1021-1034. https://doi.org/10.1002/ijc.29397 DOI: https://doi.org/10.1002/ijc.29397

[17] Y.-C. Lu, J. T. Chang, C.-T. Liao, C.-J. Kang, S.-F. Huang, I.-H. Chen, C.-C. Huang, Y.-C. Huang, W.-H. Chen, C.-Y. Tsai, H.-M. Wang, C.-H. Yen, G.-R. You, C.-H. Chiang, A.-J. Cheng, OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway, Molecular Cancer 13 (2014) 218. https://doi.org/10.1186/1476-4598-13-218 DOI: https://doi.org/10.1186/1476-4598-13-218

[18] E. Coskun, E. K. von der Heide, C. Schlee, A. Kühnl, N. Gökbuget, D. Hoelzer, W. -K. Hofmann, E. Thiel, C. D. Baldus, The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia, Leukemia Research 35 (2011) 208-213. https://doi.org/10.1016/j.leukres.2010.05.007 DOI: https://doi.org/10.1016/j.leukres.2010.05.007

[19] Y. Li, L. Jin, D. Chen, J. Liu, Z. Su, S. Yang, Y. Gui, X. Mao, G. Nie, Y. Lai, Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma, Molecular Medicine Reports 14 (2016) 560-566. https://doi.org/10.3892/mmr.2016.5251 DOI: https://doi.org/10.3892/mmr.2016.5251

[20] S. Braig, D. W. Mueller, T. Rothhammer, A.-K. Bosserhoff, MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma: PP54, Pigment Cell & Melanoma Research 22 (2009) 695. https://doi.org/10.1007/s00018-010-0394-7 DOI: https://doi.org/10.1007/s00018-010-0394-7

[21] D.-L. Zhang, X. Liu, Q. Wang, N. LI, S.-H. Wu, C. Wang, Downregulation of microRNA-196a attenuates ischemic brain injury in rats by directly targeting HMGA1, European Review for Medical & Pharmacological Sciences 23 (2019) 740-748. https://doi.org/10.26355/eurrev_201901_16888

[22] X. Dong, S. Cong, MicroRNAs in Huntington’s disease: diagnostic biomarkers or therapeutic agents?, Frontiers in Cellular Neuroscience 15 (2021) 705348. https://doi.org/10.3389/fncel.2021.705348 DOI: https://doi.org/10.3389/fncel.2021.705348

[23] P. Brest, P. Lapaquette, M. Souidi, K. Lebrigand, A. Cesaro, V. Vouret-Craviari, B. Mari, P. Barbry, J. F. Mosnier, X. Hébuterne, A. Harel-Bellan, B. Mograbi, A. Darfeuille-Michaud, P. Hofman, A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease, Nature Genetics 43 (2011) 242-245. https://doi.org/10.1038/ng.762 DOI: https://doi.org/10.1038/ng.762

[24] K. Yang, S. Feng, J. Ren, W. Zhou, Upregulation of microRNA‐196a improves cognitive impairment and alleviates neuronal damage in hippocampus tissues of Alzheimer's disease through downregulating LRIG3 expression, Journal of Cellular Biochemistry 120 (2019) 17811-17821. https://doi.org/10.1002/jcb.29047 DOI: https://doi.org/10.1002/jcb.29047

[25] B. Liu, Y. Xiang, H. S. Zhang, Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C, Molecular Medicine Reports 12 (2015) 105-110. https://doi.org/10.3892/mmr.2015.3386 DOI: https://doi.org/10.3892/mmr.2015.3386

[26] N. Fujimor, Y. Minoda, Y. Ogawa, What is the best modality for diagnosing pancreatic cancer, Digestive Endoscopy 34 (2022) 744-746. https://doi.org/10.1111/den.14283 DOI: https://doi.org/10.1111/den.14283

[27] J. Yang, R. Xu, C. Wang, J. Qiu, B. Ren, L. You, Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review, Cancer Communications (London, England) 41 (2021) 1257-1274. https://doi.org/10.1002/cac2.12204 DOI: https://doi.org/10.1002/cac2.12204

[28] E. Buscail, C. Maulat, F. Muscari, L. Chiche, P. Cordelier, S. Dabernat, C. Alix-Panabières, L. Buscail, Liquid biopsy approach for pancreatic ductal adenocarcinoma, Cancers 11 (2019) 852. https://doi.org/10.3390/cancers11060852 DOI: https://doi.org/10.3390/cancers11060852

[29] S. Kreth, M. Hübner, L. C. Hinske, MicroRNAs as clinical biomarkers and therapeutic tools in perioperative medicine, Anesthesia & Analgesia 126 (2018) 670-681. https://doi.org/10.1213/ANE.0000000000002444 DOI: https://doi.org/10.1213/ANE.0000000000002444

[30] T. F. H. Lestari, I. Irkham, U. Pratomo, S. Gaffar, S. N. Zakiyyah, I. Rahmawati, S.N. Topkaya, Y.W. Hartati, Label-free and label-based electrochemical detection of disease biomarker proteins, ADMET & DMPK 12 (2024) 463-486. https://doi.org/10.5599/admet.2162 DOI: https://doi.org/10.5599/admet.2162

[31] X. Dong, X. Lu, K. Zhang, Y. Zhang, Chronocoulometric DNA biosensor based on a glassy carbon electrode modified with gold nanoparticles, poly (dopamine) and carbon nanotubes, Microchimica Acta 180 (2013) 101-108. https://doi.org/10.1007/s00604-012-0900-8 DOI: https://doi.org/10.1007/s00604-012-0900-8

[32] S. Campuzano, P. Yáñez-Sedeño, J. M. Pingarrón, Electrochemical genosensing of circulating biomarkers, Sensors 17 (2017) 866. https://doi.org/10.3390/s17040866 DOI: https://doi.org/10.3390/s17040866

[33] K. Namsheer, C. S. Rout, Conducting polymers: a comprehensive review on recent advances in synthesis, properties and applications, RSC Advances 11 (2021) 5659-5697. https://doi.org/10.1039/d0ra07800j DOI: https://doi.org/10.1039/D0RA07800J

[34] G. Paimard, E. Ghasali, M. Baeza, Screen-printed electrodes: Fabrication, modification, and biosensing applications, Chemosensors 11 (2023) 113. http://dx.doi.org/10.3390/chemosensors11020113 DOI: https://doi.org/10.3390/chemosensors11020113

[35] I. Rawashdeh, M. G. Al-Fandi, Y. Makableh, T. Harahsha, Developing a nano-biosensor for early detec¬tion of pancreatic cancer, Sensor Review 41 (2021) 93-100. https://doi.org/10.1108/SR-01-2020-0004 DOI: https://doi.org/10.1108/SR-01-2020-0004

[36] S. C. Chen, K. T. Chen, A. F. Jou, Polydopamine-gold composite-based electrochemical biosensor using dual-amplification strategy for detecting pancreatic cancer-associated microRNA, Biosensors and Bioelectronics 173 (2021) 112815. https://doi.org/10.1016/j.bios.2020.112815 DOI: https://doi.org/10.1016/j.bios.2020.112815

[37] D. Zeng, Z. Wang, Z. Meng, P. Wang, L. San, W. Wang, A. Aldalbahi, L. Li, J. Shen, X. Mi, DNA Tetrahedral Nanostructure-Based Electrochemical miRNA Biosensor for Simultaneous Detection of Multiple miRNAs in Pancreatic Carcinoma, ACS Applied Materials & Interfaces 28 (2017) 24118-24125. https://doi.org/10.1021/acsami.7b05981 DOI: https://doi.org/10.1021/acsami.7b05981

[38] J. Xu, K. Liao, Z. Fu, Z. Xiong, A new method for early detection of pancreatic cancer biomarkers: detection of microRNAs by nanochannels, Artificial Cells, Nanomedicine, and Biotechnology 47 (2019) 2634-2640. http://dx.doi.org/10.1080/21691401.2019.1614594 DOI: https://doi.org/10.1080/21691401.2019.1614594

[39] P. N. Joshi, S. Waghmode, Graphene quantum dot-based on-chip electrochemical DNA hybridization sensor for pancreatic cancer, Reports in Electrochemistry 14 (2016) 31-40. https://doi.org/10.2147/RIE.S83253 DOI: https://doi.org/10.2147/RIE.S83253

[40] J. Turkevich, P. C. Stevenson, J. Hillier, A study of the nucleation and growth processes in the synthesis of colloidal gold, Discussions of the Faraday Society 11 (1951) 55-75. https://doi.org/10.1039/DF9511100055 DOI: https://doi.org/10.1039/df9511100055

[41] G. U. Flechsig, T. Reske, Electrochemical detection of DNA hybridization by means of osmium tetroxide complexes and protective oligonucleotides, Analytical Chemistry 79 (2007) 2125-2130. https://doi.org/10.1021/ac062075c DOI: https://doi.org/10.1021/ac062075c

[42] J. Guo, C. Yuan, Q. Yan, Q. Duan, X. Li, G. Yi, An electrochemical biosensor for microRNA-196a detection based on cyclic enzymatic signal amplification and template-free DNA extension reaction with the adsorption of methylene blue, Biosensors and Bioelectronics 105 (2018) 103-108. http://dx.doi.org/10.1016/j.bios.2020.112815 DOI: https://doi.org/10.1016/j.bios.2018.01.036

[43] N. Jendrike, A. Baumstark, U. Kamecke, C. Haug, G. Freckmann, ISO 15197: 2013 evaluation of a blood glucose monitoring system’s measurement accuracy, Journal of Diabetes Science and Technology 11 (2017) 1275-1276. http://dx.doi.org/10.1177/1932296817727550 DOI: https://doi.org/10.1177/1932296817727550

Downloads

Published

15-09-2025

Issue

Vol. 15 No. 6 (2025)

Section

Bioelectrochemistry

License

Copyright (c) 2025 Namita Sharma, Sudha Srivastava

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Development of non-invasive genosensor to diagnose pancreatic cancer using miRNA-196a: Original scientific paper. (2025). Journal of Electrochemical Science and Engineering, 15(6), Article 2807. https://doi.org/10.5599/jese.2807